Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Gross Profit (2024 - 2025)

Historic Gross Profit for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2025 value amounting to $1.4 million.

  • X4 Pharmaceuticals' Gross Profit rose 32462.46% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 441066.88%. This contributed to the annual value of $1.8 million for FY2024, which is N/A changed from last year.
  • X4 Pharmaceuticals' Gross Profit amounted to $1.4 million in Q3 2025, which was up 32462.46% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Gross Profit ranged from a high of $24.1 million in Q1 2025 and a low of $295000.0 during Q2 2024